These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36890648)

  • 1. Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II.
    Criscuolo E; Giuliani B; Ferrarese R; Ferrari D; Locatelli M; Clementi M; Mancini N; Clementi N
    J Med Virol; 2023 Mar; 95(3):e28643. PubMed ID: 36890648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
    Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
    BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monkeypox virus vaccine evolution and global preparedness for vaccination.
    Chakraborty C; Bhattacharya M; Ranjan Sharma A; Dhama K
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109346. PubMed ID: 36274490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV-1 from Guangzhou, China.
    Dai J; Li F; Yang Y; Tang X; Li L; Yu H
    J Med Virol; 2023 May; 95(5):e28763. PubMed ID: 37212313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of monkeypox- and vaccinia-virus neutralizing antibodies before and after smallpox vaccination: A sero-epidemiological study.
    Marchi S; Piccini G; Cantaloni P; Guerrini N; Zannella R; Coluccio R; Benincasa L; Solfanelli N; Remarque EJ; Viviani S; Kistner O; Temperton N; Montomoli E; Manenti A; Trombetta CM
    J Med Virol; 2024 Jun; 96(6):e29728. PubMed ID: 38860589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poxvirus Vaccines: Past, Present, and Future.
    Jhancy M
    Adv Exp Med Biol; 2024; 1451():273-287. PubMed ID: 38801584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection.
    Manenti A; Solfanelli N; Cantaloni P; Mazzini L; Leonardi M; Benincasa L; Piccini G; Marchi S; Boncioli M; Spertilli Raffaelli C; Tacconi D; Mattiuzzo G; Kistner O; Montomoli E; Trombetta CM
    Front Public Health; 2023; 11():1195674. PubMed ID: 37415699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-of-the-art on monkeypox virus: an emerging zoonotic disease.
    Shafaati M; Zandi M
    Infection; 2022 Dec; 50(6):1425-1430. PubMed ID: 36192607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects.
    Sammartino JC; Cassaniti I; Ferrari A; Piralla A; Bergami F; Arena FA; Paolucci S; Rovida F; Lilleri D; Percivalle E; Baldanti F
    J Med Virol; 2023 May; 95(5):e28778. PubMed ID: 37212258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
    Hubert M; Guivel-Benhassine F; Bruel T; Porrot F; Planas D; Vanhomwegen J; Wiedemann A; Burrel S; Marot S; Palich R; Monsel G; Diombera H; Gallien S; Lopez-Zaragoza JL; Vindrios W; Taieb F; Fernandes-Pellerin S; Delhaye M; Laude H; Arowas L; Ungeheuer MN; Hocqueloux L; Pourcher V; Prazuck T; Marcelin AG; Lelièvre JD; Batéjat C; Lévy Y; Manuguerra JC; Schwartz O
    Cell Host Microbe; 2023 Jun; 31(6):937-948.e4. PubMed ID: 37196656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
    Xia A; Wang X; He J; Wu W; Jiang W; Xue S; Zhang Q; Gao Y; Han Y; Li Y; Peng X; Xie M; Mayer CT; Liu J; Hua C; Sha Y; Xu W; Huang J; Ying T; Jiang S; Xie Y; Cai Q; Lu L; Silva IT; Yuan Z; Zhang Y; Wang Q
    BMC Biol; 2023 Oct; 21(1):205. PubMed ID: 37784185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation?
    Mariotti S; Venturi G; Chiantore MV; Teloni R; De Santis R; Amendola A; Fortuna C; Marsili G; Grilli G; Lia MS; Kiros ST; Lagi F; Bartoloni A; Iacobino A; Cresta R; Lastilla M; Biselli R; Di Bonito P; Lista F; Nisini R
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.
    Zaeck LM; Lamers MM; Verstrepen BE; Bestebroer TM; van Royen ME; Götz H; Shamier MC; van Leeuwen LPM; Schmitz KS; Alblas K; van Efferen S; Bogers S; Scherbeijn S; Rimmelzwaan GF; van Gorp ECM; Koopmans MPG; Haagmans BL; GeurtsvanKessel CH; de Vries RD
    Nat Med; 2023 Jan; 29(1):270-278. PubMed ID: 36257333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
    Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies.
    Sudarmaji N; Kifli N; Hermansyah A; Yeoh SF; Goh BH; Ming LC
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of monkeypox with vaccines: a rapid review.
    Poland GA; Kennedy RB; Tosh PK
    Lancet Infect Dis; 2022 Dec; 22(12):e349-e358. PubMed ID: 36116460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
    Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD
    Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus.
    Li E; Guo X; Hong D; Gong Q; Xie W; Li T; Wang J; Chuai X; Chiu S
    Signal Transduct Target Ther; 2023 Sep; 8(1):350. PubMed ID: 37709783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against monkeypox.
    Reina J; Iglesias C
    Med Clin (Barc); 2023 Apr; 160(7):305-309. PubMed ID: 36775782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.